Physician profile
Steven A Morgan
NPI 1609882554
$2,275.11
in general payments reported to CMS, 2019-2025
21 companies · $213 in 2025
The $213 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $430 · 2020: $112 · 2021: $262 · 2022: $758 · 2023: $451 · 2024: $49.09 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $486.42 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Hologic Sales and Service, LLC | $300.34 | 2022-2023 | Myosure Tissue Removal Device |
| Lupin INC. | $196.83 | 2019-2020 | |
| Gynesonics, INC. | $169.80 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Abbvie INC. | $160.48 | 2020-2023 | |
| Davol INC. | $140.09 | 2021 | |
| Smith+Nephew, INC. | $138.85 | 2019 | |
| Bioxcel Therapeutics, INC. | $124.09 | 2023 | Igalmi |
| Mayne Pharma Commercial LLC | $122.32 | 2023-2025 | |
| Mallinckrodt Hospital Products INC. | $95.96 | 2022 | |
| Allergan, INC. | $69.58 | 2019-2020 | |
| Evofem Biosciences, INC. | $67.65 | 2021-2024 | |
| Avion Pharmaceuticals | $38.12 | 2019-2020 | |
| Coopersurgical, INC. | $38.11 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.34 | 2020-2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.24 | 2023 | |
| Therapeuticsmd, INC. | $17.48 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.54 | 2019 | |
| Roche Diagnostics Corporation | $13.74 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.24 | 2019 | |
| Organon LLC | $11.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Morgan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.